| Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology T Skjørringe, A Burkhart, KB Johnsen, T Moos Frontiers in molecular neuroscience 8, 19, 2015 | 93 | 2015 |
| Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma. KB Johnsen, A Burkhart, T Moos Scientific reports, 2007 | 91* | 2007 |
| A triple culture model of the blood-brain barrier using porcine brain endothelial cells, astrocytes and pericytes LB Thomsen, A Burkhart, T Moos PloS one 10 (8), e0134765, 2015 | 87 | 2015 |
| Expression of iron-related proteins at the neurovascular unit supports reduction and reoxidation of iron for transport through the blood-brain barrier A Burkhart, T Skjørringe, KB Johnsen, P Siupka, LB Thomsen, MS Nielsen, ... Molecular neurobiology 53 (10), 7237-7253, 2016 | 50 | 2016 |
| Targeting the transferrin receptor for brain drug delivery KB Johnsen, A Burkhart, LB Thomsen, TL Andresen, T Moos Progress in neurobiology 181, 101665, 2019 | 41 | 2019 |
| Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood–brain barrier MS Thomsen, S Birkelund, A Burkhart, A Stensballe, T Moos Journal of neurochemistry 140 (5), 741-754, 2017 | 37 | 2017 |
| Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles KB Johnsen, M Bak, PJ Kempen, F Melander, A Burkhart, MS Thomsen, ... Theranostics 8 (12), 3416, 2018 | 36 | 2018 |
| Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo KB Johnsen, M Bak, F Melander, MS Thomsen, A Burkhart, PJ Kempen, ... Journal of Controlled Release 295, 237-249, 2019 | 34 | 2019 |
| Transfection of brain capillary endothelial cells in primary culture with defined blood–brain barrier properties A Burkhart, LB Thomsen, MS Thomsen, J Lichota, C Fazakas, I Krizbai, ... Fluids and Barriers of the CNS 12 (1), 1-14, 2015 | 32 | 2015 |
| Accessing targeted nanoparticles to the brain: the vascular route A Burkhart, M Azizi, MS Thomsen, LB Thomsen, T Moos Current medicinal chemistry 21 (36), 4092-4099, 2014 | 12 | 2014 |
| Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain A Burkhart, TL Andresen, A Aigner, LB Thomsen, T Moos Cellular and Molecular Life Sciences 74 (13), 2467-2485, 2017 | 9 | 2017 |
| Nanoparticle-derived non-viral genetic transfection at the blood-brain barrier to enable neuronal growth factor delivery by secretion from brain endothelium L B Thomsen, A B Larsen, J Lichota, T Moos Current medicinal chemistry 18 (22), 3330-3334, 2011 | 8 | 2011 |
| Hepcidin mediates transcriptional changes in ferroportin mRNA in differentiated neuronal-like PC12 cells subjected to iron challenge SS Helgudottir, J Lichota, A Burkhart, T Moos Molecular neurobiology 56 (4), 2362-2374, 2019 | 3 | 2019 |
| Gene therapy to the blood–brain barrier with resulting protein secretion as a strategy for treatment of Niemann Picks type C2 disease E Hede, CB Christiansen, CW Heegaard, T Moos, A Burkhart Journal of neurochemistry, 2020 | 2 | 2020 |
| Targeting immunoliposomes to transferrin receptors on brain capillary endothelial cells as a mean for cargo transport across the blood-brain barrier KB Johnsen, AB Larsen, J Bruun, P Siupka, MS Nielsen, TL Andresen, ... Final Programme, 19th International Symposium on Signal Transduction at the …, 2016 | 2 | 2016 |
| The blood-brain barrier in vitro using primary culture: implications for studies of therapeutic gene expression and iron transport AB Larsen River Publishers, 2014 | 2 | 2014 |
| Gene therapy to the blood-brain barrier with resulting protein secretion as a strategy for treatment of NPC2 disease E Hede, C Heegaard, J Koerbelin, M Schwanninger, T Moos, A Burkhart Human Gene Therapy 30 (11), A100-A101, 2019 | 1 | 2019 |
| Correction to: Hepcidin Mediates Transcriptional Changes in Ferroportin mRNA in Differentiated Neuronal-like PC12 Cells Subjected to Iron Challenge SS Helgudottir, J Lichota, A Burkhart, T Moos Molecular neurobiology 56 (4), 2375-2378, 2019 | 1 | 2019 |
| Expression and deposition of basement membrane proteins by brain capillary endothelial cells in a primary murine model of the blood-brain barrier MS Thomsen, S Birkelund, AB Larsen, A Stensballe, T Moos Final Programme, 19th International Symposium on Signal Transduction at the …, 2016 | 1 | 2016 |
| Epigenetic Regulation of Ferroportin in Primary Cultures of the Rat Blood-Brain Barrier SS Helgudottir, LJ Routhe, A Burkhart, K Jønsson, IS Pedersen, J Lichota, ... Molecular Neurobiology 57 (8), 3526-3539, 2020 | | 2020 |
Torben MoosAalborg UniversityVerified email at hst.aau.dk
